1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Clonal Hematopoiesis of Indeterminate Potential (CHIP): new trials by email Literature Review of Clonal Hematopoiesis of Indeterminate Potential (CHIP) trials Research Report on Clonal Hematopoiesis of Indeterminate Potential (CHIP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) MAS825, MAS825 Placebo, DFV890 - Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP) | Phase 2 | Completed | Novartis Pharmaceuticals | 31 | 2024-02-15 | 2026-04-09 |
Coronary Disease (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
Canada (1) · Germany (1) · United States (1)
2023 (1)